<unk>  (also termed: EBV<unk>  diffuse large B cell lymphoma, NOS; EBV+ DLBCL, NOS; or EBV+ DLBCL) was initially termed in the WHO 2008 classification as Epstein–Barr virus-positive DLBCL of the elderly because it was a specific type of large B-cell lymphoma that appeared to be limited to elderly (e.g. >50 years old) individuals. Since this 2008 WHO classification, however, the disorder has been diagnosed in much younger adults and children. Accordingly, the WHO classification of 2016 renamed this order as EBV+ DLBCL, NOS. The disease is also classified as one of numerous related and interrelated Epstein-Barr virus-associated lymphoproliferative diseases. EBV+ DLBCL, NOS is usually CD20<unk> , and has clonal immunoglobulin gene rearrangement. __TOC__
Epstein–Barr virus positive diffuse large B-cell lymphoma, not otherwise specified
ALK+ large B-cell lymphoma
Nodular lymphocyte predominant Hodgkin lymphoma
Pediatric-type follicular lymphoma
Germinal center B-cell like diffuse large B-cell lymphoma
Non-mycosis fungoides CD30− cutaneous large T-cell lymphoma
Fibrin-associated diffuse large B-cell lymphoma
Epstein–Barr virus–associated lymphoproliferative diseases